RECRUITING

PCORI-CER-1306-03385 Lung Cancer Screening Decision Aid Development and Testing

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

Objectives: This protocol addresses the first phase of a larger project funded by the Patient-Centered Outcomes Research Institute to help heavy smokers make informed decisions about lung cancer screening with low-dose computed tomography (CT). A separate IRB protocol will be submitted for the larger, comparative study. In this initial development phase, our prototype patient decision aid will be updated to reflect current guidelines about lung cancer screening. The updated aid will then be pilot-tested in a new sample of patients. In addition, several of the study measures will be refined and further developed in preparation for the larger study. The specific aims of the measures and decision aid development phase of this project are as follows: Update the aid to reflect current screening guidelines and refine the aid via cognitive testing with patients/smokers; and pilot test the updated aid for acceptability with patients/smokers. Modify our current measure of lung cancer knowledge, conduct cognitive testing of the new measure with patients/smokers, and evaluate the reliability of the new measure in a sample patients/smokers.

Official Title

Promoting Informed Decisions About Lung Cancer Screening: Decision Aid Update and Measures Development

Quick Facts

Study Start:2014-07-11
Study Completion:2025-08-31
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT02282969

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:55 Years to 80 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. 1. Men and women 55 to 80 years of age.
  2. 2. Participants must speak English.
  3. 3. Current smoker or quit smoking within the past 15 years.
  1. 1. History of lung cancer.

Contacts and Locations

Study Contact

Robert Volk, PHD
CONTACT
713-563-2509
BVolk@mdanderson.org

Principal Investigator

Robert Volk, PHD
STUDY_CHAIR
M.D. Anderson Cancer Center
Suzanne Linder, PHD
PRINCIPAL_INVESTIGATOR
The University of Texas Medical Branch at Galveston
Paul Cinciripini, PHD, MS, BS
PRINCIPAL_INVESTIGATOR
M.D. Anderson Cancer Center

Study Locations (Sites)

The University of Texas Medical Branch at Galveston
Galveston, Texas, 77555
United States
University of Texas MD Anderson Cancer Center
Houston, Texas, 77030
United States

Collaborators and Investigators

Sponsor: M.D. Anderson Cancer Center

  • Robert Volk, PHD, STUDY_CHAIR, M.D. Anderson Cancer Center
  • Suzanne Linder, PHD, PRINCIPAL_INVESTIGATOR, The University of Texas Medical Branch at Galveston
  • Paul Cinciripini, PHD, MS, BS, PRINCIPAL_INVESTIGATOR, M.D. Anderson Cancer Center

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2014-07-11
Study Completion Date2025-08-31

Study Record Updates

Study Start Date2014-07-11
Study Completion Date2025-08-31

Terms related to this study

Keywords Provided by Researchers

  • Cancer Prevention
  • Smokers
  • Quit smoking
  • Interviews
  • Questionnaires
  • Surveys
  • Lung cancer screening
  • Patient decision aid

Additional Relevant MeSH Terms

  • Health Knowledge, Attitudes, Practice